Søgning på udtrykket 'hepatitis' giver 110 resultater
Dokumenter [13]
Sider [4]
Kalender [51]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dokumenter [13]
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Se…
Diagnostik, behandling og forebyggelse af infektion med hepatitis A virus (HAV)
Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).
Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab
Revideret september 2020. Arbejdsgruppen bestod af Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis
Bilag til Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)
Sider [4]
…At orientere DSI's bestyrelse ved nye medlemmer i gruppen, eller hvis medlemmer udgår efter ønske eller ved inaktivitet.,
Nedenfor vises selskabets repræsentanter i diverse arbejdsgrupper og udvalg, og publicerede guidelines.
Akut viral hepatitis:
Carsten Shade Larsen og Nina Weis.
Hepatitis A (2013),
Antiretroviral terapi:
Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Isik Somuncu, Gitte Kronborg, Ann-Brit Eg Hansen
Antiviral behandling af…
…ioner:
Dato for næste kursus
Efterår 2024 (2 dage) :
Sted
Endnu ikke afklaret
Delkursusledelse
Jakob Bodilsen og Lars Omland
Tidligere kurser
11. og 12. april 2018
9. og 10 september 2021
Gastroenterologiske infektioner og kronisk hepatitis:
Dato for næste kursus
2026:
Sted
Odense Universitetshospital
Delkursusledelse
Lone Mygind, Micha Jepsen og Belinda Mössner
Tidligere kurser
4. og 5. december 2023
3. og 4. december 2020
HIV-infektion:
Næste kursus
Ef…
…ogiske oversigter (slides).
www.natap.org/. National AIDS Treatment Advocacy Project ? en New York State non-profit NGO ledet af Jules Levin (som selv lever med Hiv og hepatitis). God side, hvis man mangler slides/figurer/tabeller fra studier præsenteret på senest afholdte konferencer kommer ofte med referat (inklusive Jules Levins fortolkning ud fra et patient/aktivist perspektiv).
www.clinicaloptions.com/HIV.aspx. Et andet website for opdateringer og sammendrag af konferencer (slides).
Professor Henrik Nielsen kommenterer: I disse år sker et paradigmeskift i behandlingen af kronisk hepatitis C virus infektionen. Mange direkte virkende lægemidler er i afprøvning og med lovende resultater. Snart er interferon-baseret terapi ikke absolut nødvendig, mens oral terapi af kort varighed synes indenfor rækkevidde. Samtidigt er bivirkninger ved de nye lægemidler hidtil beskrevet som milde og sjældne. Kombination af sofosbuvir og ledipasvir i samme tablet bliver muligvis den første effektive…
Professor Nina Weis kommenterer: Kronisk hepatitis B, forårsaget af forekomst af hepatitis B virus i blodet i > 6 måneder, kan klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom.
Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark. Aktuelt er eneste behandlingstilbud (ofte livslang) antiviral terapi.
Denne artikel gennemgår naturhistorien, kendte og nye biomark…
Kalender [51]
4. december 2023, Odense Universitetshospital
27. oktober 2023, Vandrehal lokale 3, Hvidovre Hospital
25. september 2023, Hvidovre Hospital
7. juni 2023, Rom, Italien
2. juni 2023, Auditorium 3 og 4, Hvidovre Hospital
26. oktober 2022, Auditorium 3 and 4, Hvidovre Hospital
17. juni 2022, Auditorium 3+4, Hvidovre Hospital
10. maj 2022, Auditorium 3+4, Hvidovre Hospital
3. december 2020, Hvidovre Hospital
28. oktober 2020, Paris, Frankrig
17. september 2020, Auditorium 3-4, Hvidovre Hospital
25. november 2019, Auditorium 3 og 4, Hvidovre Hospital
25. september 2019, London, England
11. september 2019, DGI-byen, København
21. juli 2019, Mexico City, Mexico
22. maj 2019, Rom, Italien
10. maj 2019, Auditorium 3 og 4, Hvidovre Hospital
15. februar 2019, Auditorium, University of Southern Denmark, J. B. Winsløws Vej 25, Odense
24. januar 2019, Aarhus Universitetshospital
28. november 2018, Hvidovre Hospital
30. maj 2018, Rom, Italien
4. maj 2018, Hindsgavl, Middelfart
9. april 2018, Amsterdam, Holland
27. februar 2018, Hvidovre Hospital
12. december 2017, Auditorium 3 og 4, Hvidovre Hospital
14. september 2017, IDA Mødecenter, Kalvebod Brygge 31, 1560 København V
30. maj 2017, Hvidovre Hospital
13. oktober 2016, Auditoriet, Syddansk Universitet
25. maj 2016, Rom, Italien
3. juni 2015, Barcelona, Spanien
24. marts 2015, Auditorium 3+4, Hvidovre Hospital
13. november 2014, Auditorium 3-4, Hvidovre Hospital
24. oktober 2014, Rigshospitalet
9. oktober 2014, Frankfurt, Tyskland
18. juli 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
5. juli 2014, Sigtuna, Sverige
23. maj 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
1. maj 2014, Berlin, Tyskland
26. marts 2014, Barcelona, Spanien
30. juni 2013, Kuala Lumpur, Malaysia
20. marts 2013, Rom, Italien
3. marts 2013, Atlanta, Georgia, USA
25. oktober 2012, Danmarks Medie- og Journalisthøjskole
18. oktober 2012, Berlin, Tyskland
7. november 2011, Auditorium 93, Rigshospitalet
24. maj 2011, Rigshospitalet, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Emerg Microbes Infect
17.04.2024
Volume 13, Issue 1, December 2024 .
Journal of Infectious Diseases
17.04.2024
Abstract . Background . We evaluated long-term trajectories of circulating hepatitis B virus (HBV)-RNA and hepatitis B core-related antigen (HBcrAg) in persons with and without hepatitis B surface antigen (HBsAg) loss during tenofovir therapy in the Swiss HIV Cohort Study.Methods . We included 29 persons with HIV (PWH) with HBsAg loss and 29 matched PWH without loss. We compared HBV-RNA and HBcrAg decline and assessed the cumulative proportions with undetectable HBV-RNA and HBcrAg levels during tenofovir th…
Emerg Microbes Infect
12.04.2024
Volume 13, Issue 1, December 2024 .
BMC Infectious Diseases
10.04.2024
… Background. Highly active antiretroviral therapy (HAART) has been able to improve the immune system function and survival of human immunodeficiency virus (HIV) patients. However, Patients coinfected with HIV and hepatitis B virus (HBV) are more likely to develop end-stage liver disease (ESLD) than those infected with HBV alone. Consequently, liver transplantation is often required for these patients. This study evaluates the outcomes of orthotopic liver transplant…
BMC Infectious Diseases
9.04.2024
… Background. Highly active antiretroviral therapy (HAART) has been able to improve the immune system function and survival of human immunodeficiency virus (HIV) patients. However, Patients coinfected with HIV and hepatitis B virus (HBV) are more likely to develop end-stage liver disease (ESLD) than those infected with HBV alone. Consequently, liver transplantation is often required for these patients. This study evaluates the outcomes of orthotopic liver transplant…
Journal of Medical Virology
5.04.2024
Journal of Medical Virology, Volume 96, Issue 4, April 2024.
Clinical Infectious Diseases
5.04.2024
Abstract . We evaluated vertical transmission and linkage to care in women with HCV and history of injection drug use employing co-localized testing and treatment. Transmission occurred in 1 of 23 infants, with mother-infant genetic distance of 1.26%. Rates for infant testing, maternal linkage and cure were 77%, 52%, and 100%, respectively.
Lancet
5.04.2024
A 78-year-old man with primary central nervous system lymphoma was transferred to our cancer centre for further treatment. The patient had been diagnosed 3 months earlier after he presented to another hospital with back pain, numbness, and tingling in all extremities; he had two cycles of rituximab and high-dose methotrexate, which had produced a partial response. The patient had also been given dexamethasone for cerebral oedema; his medical history included type 2 diabetes, hypertension, and coronary arter…
American Journal of Tropical Medicine and Hygiene
3.04.2024
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 110 Issue: 4 Pages: 719-723. .
Virulence
3.04.2024
Volume 15, Issue 1, December 2024 .
Clinical Infectious Diseases
2.04.2024
Abstract . Background . Evaluation of the impact on mother-to-child transmission (MTCT) of a HBV-prevention program that incorporates maternal antiviral prophylaxis is hindered by the limited availability of real-world data.Methods . This study analyzed data on maternal HBV screening, neonatal immunization, and post-vaccination serologic testing (PVST) for HBsAg among at-risk infants born to HBV carrier mothers from the National Immunization Information System during 01/01/2008–31/12/2022. Through linkage…
BMC Infectious Diseases
31.03.2024
. Abstract. This comprehensive retrospective data-linkage study aimed at evaluating the impact of Direct-Acting Antivirals (DAAs) on Hepatitis C Virus (HCV) testing, treatment trends, and access to care in Tuscany over six years following their introduction. Utilizing administrative healthcare records, our work reveals a substantial increase in HCV tests in 2017, attributed to the decision to provide universal access to treatment. However, despite efforts to eradicate…
BMC Infectious Diseases
30.03.2024
. Abstract. This comprehensive retrospective data-linkage study aimed at evaluating the impact of Direct-Acting Antivirals (DAAs) on Hepatitis C Virus (HCV) testing, treatment trends, and access to care in Tuscany over six years following their introduction. Utilizing administrative healthcare records, our work reveals a substantial increase in HCV tests in 2017, attributed to the decision to provide universal access to treatment. However, despite efforts to eradicate…
BMC Infectious Diseases
30.03.2024
. Abstract. . Background. There are abundant studies on COVID-19 but few on its impact on hepatitis E. We aimed to assess the effect of the COVID-19 countermeasures on the pattern of hepatitis E incidence and explore the application of time series models in analyzing this pattern. . . . Methods. Our pivotal idea was to fit a pre-COVID-19 mod…
BMC Infectious Diseases
30.03.2024
…e sex with men (MSM) are a key population group disproportionately affected by HIV and other sexually transmitted infections (STIs) worldwide. In Rwanda, the HIV epidemic remains a significant public health concern, and understanding the burden of HIV and hepatitis B and C coinfections among MSM is crucial for designing effective prevention and control strategies. This study aims to determine the prevalence of HIV, hepatitis B, and hepatitis C infections among MSM in Rwanda and identify correlates associate…
PLoS One Infectious Diseases
28.03.2024
by Hareton Teixeira Vechi, Mônica Baumgardt Bay, Cláudio Henrique Silva de Freitas, Júlia Gomes Fernandes Costa de Sant’anna, Carlos Brites, Kenio Costa de Lima . Hepatitis A virus (HAV) infection has disproportionately affected more men who have sex with men (MSM), occurring in outbreaks, despite being vaccine-preventable. We determined the prevalence and factors associated with HAV susceptibility among cisgender MSM on HIV pre-exposure prophylaxis (PrEP) in Northeastern Brazil. From September 30, 20…
Journal of Infectious Diseases
28.03.2024
Abstract . Background . The global incidence target for the elimination of hepatitis C among people who inject drugs (PWID) is
Clinical Infectious Diseases
28.03.2024
Abstract . Background . Improved epidemiologic and treatment data for active tuberculosis (TB) with chronic hepatitis B virus (cHBV) infection might inform and encourage screening and vaccination programs focused on persons at risk of having both conditions.Methods . We matched the California Department of Public Health TB registry during 2016–2020 to the cHBV registry using probabilistic matching algorithms. We used chi-square analysis to compare the characteristics of persons with TB and cHBV with those…
BMC Infectious Diseases
28.03.2024
. Abstract. . Background. There are abundant studies on COVID-19 but few on its impact on hepatitis E. We aimed to assess the effect of the COVID-19 countermeasures on the pattern of hepatitis E incidence and explore the application of time series models in analyzing this pattern. . . . Methods. Our pivotal idea was to fit a pre-COVID-19 mod…
Clinical Infectious Diseases
25.03.2024
HCVPOCantibodyRNAPWID
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Medscape Infectious Diseases
8.04.2024
While the hepatitis E virus causes tens of thousands of deaths each year, data suggest that a vaccine approved in China has long-term efficacy. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
16.02.2024
This report describes Correctional Health Services and LA County Jail's response to a confirmed case of Hepatitis A in a person who is incarcerated.
Medscape Infectious Diseases
1.12.2023
At least 450 patients at Mass General Brigham, Salem Hospital, near Boston are at risk of HIV and hepatitis infection, according to a lawsuit claiming negligent intravenous medication administration. . Medscape Medical News
Medscape Infectious Diseases
11.11.2023
A scientist whose work was key to identifying, studying, and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist. . Knowable Magazine
Morbidity and Mortality Weekly Report (MMWR)
1.11.2023
CDC reports on CDC recommendations for hepatitis C testing among perinatally exposed infants and children in the United States in 2023.
Medscape Infectious Diseases
20.10.2023
Despite ongoing hostilities, healthcare professionals take mobile clinics to their fellow Ukrainians, as the battle extends to fighting the country's high levels of hepatitis C. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
19.10.2023
This report describes deaths related to hepatitis A outbreaks.
Eurosurveillance latest updates
22.09.2023
On 5 April 2022, the United Kingdom reported an increase of cases of severe acute hepatitis of unknown aetiology in children, several needing hospitalisation and some required liver transplant or died. Thereafter, 35 countries reported probable cases, almost half of them in Europe. Facing the alert, on 28 April, Portugal created a multidisciplinary Task Force (TF) for rapid detection of probable cases and response. The experts of the TF came from various disciplines: clinicians, laboratory experts, epidemio…
Medscape Infectious Diseases
23.08.2023
Mortality rates remain substantially elevated after successful treatment of hepatitis C infection in the era of interferon-free antiviral therapy, a study of over 20,000 patients has found. . Medscape Medical News
Eurosurveillance latest updates
28.07.2023
. Background. The burden of chronic hepatitis B virus (HBV) varies across the European Union (EU) and European Economic Area (EEA). . . Aim. We aimed to update the 2017 HBV prevalence estimates in EU/EEA countries and the United Kingdom for 2018 to 2021. . . Methods. We undertook a systematic review, adding to HBV prevalence estimates from an existing (2005–2017) database. Databases were searched for original English-language research articles including HBV surface antigen prevalence estimates among t…
Eurosurveillance latest updates
28.07.2023
. Background. Georgia has adopted the World Health Organization European Region’s and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus (HBV) surface antigen (HBsAg) and 25.9% for antibodies against HBV core antigen (anti-HBc). HBV infection prevalence among children had previously not been assessed. . . Aim. We aimed to assess HBV infection prevalence among children and update estimates for adults in Georgia. . . Metho…
Eurosurveillance latest updates
28.07.2023
. Background. Between May 2015 and February 2022, 77,168 hepatitis C virus (HCV)-infected people in Georgia have been treated through an HCV elimination programme. To project the programme’s long-term impacts, an HCV infection model was initially developed, based on data from surveys among people who inject drugs and a national serosurvey in 2015. . . Aim. Accounting for follow-up surveys in 2021, we validate and update projections of HCV infection prevalence and incidence. . . Method. We assessed the…
Medscape Infectious Diseases
28.07.2023
Managing alcohol-associated hepatitis following hospital discharge requires treating not only the liver disease but also the underlying alcohol use disorder, says a clinical care review. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
21.07.2023
This report describes progress towards hepatitis B control and elimination in the World Health Organization African region.
Medscape Infectious Diseases
15.07.2023
World Hepatitis Day is an opportunity to remind people of the impact of viral hepatitis and to offer information that can help prevent, diagnose, and treat these diseases, said one expert. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
14.07.2023
This report describes new CDC guidance for completing hepatitis C virus testing.
Morbidity and Mortality Weekly Report (MMWR)
1.07.2023
This report describes progress towards achieving hepatitis C viral clearance by 2030.
Medscape Infectious Diseases
28.06.2023
Vaccination rates for hepatitis B virus are slightly lower among patients with psoriasis than among people without psoriasis. . Medscape Medical News
Eurosurveillance latest updates
16.06.2023
Echovirus 11 (E11) has recently been associated with a series of nine neonatal cases of severe hepatitis in France. Here, we present severe hepatitis caused by E11 in a pair of twins. In one of the neonates, the clinical picture evolved to fulminant hepatitis. The E11 genome showed 99% nucleotide identity with E11 strains reported in the cases in France. Rapid genome characterisation using next generation sequencing is essential to identify new and more pathogenetic variants.
Morbidity and Mortality Weekly Report (MMWR)
1.06.2023
This report describes the effectiveness of the Cherokee Nation Health Services hepatitis C elimination program after 5 years.